Jump to navigation Jump to search
External IDsGeneCards: [1]
RefSeq (mRNA)



RefSeq (protein)



Location (UCSC)n/an/a
PubMed searchn/an/a
View/Edit Human

CD23, also known as Fc epsilon RII, or FcεRII, is the "low-affinity" receptor for IgE, an antibody isotype involved in allergy and resistance to parasites, and is important in regulation of IgE levels. Unlike many of the antibody receptors, CD23 is a C-type lectin. It is found on mature B cells, activated macrophages, eosinophils, follicular dendritic cells, and platelets.

There are two forms of CD23: CD23a and CD23b. CD23a is present on follicular B cells, whereas CD23b requires IL-4 to be expressed on T-cells, monocytes, Langerhans cells, eosinophils, and macrophages.[1]


CD23 is known to have a role of transportation in antibody feedback regulation. Antigens which enter the blood stream can be captured by antigen specific IgE antibodies. The IgE immune complexes that are formed bind to CD23 molecules on B cells, and are transported to the B cell follicles of the spleen. The antigen is then transferred from CD23+ B cells to CD11c+ antigen presenting cells. The CD11c+ cells in turn present the antigen to CD4+ T cells, which can lead to an enhanced antibody response.[2]

Clinical significance

The allergen responsible in dust mite allergy Der p 1 is known to cleave CD23 from a cells surface. As CD23 is soluble, it can move freely and interact with cells in plasma. Recent studies have shown that increased levels of soluble CD23 cause the recruitment of non-sensitised B-cells in the presentation of antigen peptides to allergen-specific B-cells, therefore increasing the production of allergen specific IgE. IgE, in turn, is known to upregulate the cellular expression of CD23 and Fc epsilon RI (high-affinity IgE receptor).

In flow cytometry, CD23 is helpful in the differentiation of chronic lymphocytic leukemia (CD23-positive) from mantle cell lymphoma (CD23-negative).[3] CD23 can also be demonstrated in germinal centre B-cells using immunohistochemistry, but it is not present in the resting cells of the surrounding mantle zone. Lymphomas arising from the mantle zone are generally negative for CD23, but most B-cell chronic lymphomocytic leukaemias and low-grade B-cell lymphomas are positive, allowing immunohistochemistry to distinguish these conditions, which otherwise have a similar appearance. Reed–Sternberg cells are usually positive for CD23.[4]

See also


  1. Lichtman AH, Abbas AK (2003). Cellular and molecular immunology. Philadelphia: Saunders. pp. 324–325. ISBN 0-7216-0008-5.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  2. Henningsson F, Ding Z, Dahlin JS, Linkevicius M, Carlsson F, Grönvik KO, Hallgren J, Heyman B (2011). Metzger DW, ed. "IgE-mediated enhancement of CD4+ T cell responses in mice requires antigen presentation by CD11c+ cells and not by B cells". PLOS ONE. 6 (7): e21760. doi:10.1371/journal.pone.0021760. PMC 3130775. PMID 21765910.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  3. Barna G, Reiniger L, Tátrai P, Kopper L, Matolcsy A (Sep 2008). "The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL". Hematological Oncology. 26 (3): 167–70. doi:10.1002/hon.855. PMID 18381689.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  4. Cooper K, Leong AS (2003). Manual of diagnostic antibodies for immunohistology. London: Greenwich Medical Media. p. 95. ISBN 1-84110-100-1.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>

Further reading

<templatestyles src="Refbegin/styles.css" />

  • Kijimoto-Ochiai S (Apr 2002). "CD23 (the low-affinity IgE receptor) as a C-type lectin: a multidomain and multifunctional molecule". Cellular and Molecular Life Sciences : CMLS. 59 (4): 648–64. doi:10.1007/s00018-002-8455-1. PMID 12022472.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Schwarzmeier JD, Hubmann R, Düchler M, Jäger U, Shehata M (Feb 2005). "Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia". Leukemia & Lymphoma. 46 (2): 157–65. doi:10.1080/10428190400010742. PMID 15621797.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Maekawa N, Kawabe T, Sugie K, Kawakami T, Iwata S, Uchida A, Yodoi J (May 1992). "Induction of Fc epsilon RII/CD23 on PHA-activated human peripheral blood T lymphocytes and the association of Fyn tyrosine kinase with Fc epsilon RII/CD23". Research in Immunology. 143 (4): 422–5. doi:10.1016/S0923-2494(05)80075-6. PMID 1387715.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Rose K, Turcatti G, Graber P, Pochon S, Regamey PO, Jansen KU, Magnenat E, Aubonney N, Bonnefoy JY (Sep 1992). "Partial characterization of natural and recombinant human soluble CD23". The Biochemical Journal. 286 ( Pt 3) (Pt 3): 819–24. PMC 1132977. PMID 1417742.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Maekawa N, Kawabe T, Sugie K, Kawakami T, Maeda Y, Uchida A, Yodoi J (1992). "Induction of Fc epsilon RII/CD23 on PHA-activated human peripheral blood T lymphocytes and association of fyn tyrosine kinase with Fc epsilon RII/CD23". International Journal of Tissue Reactions. 14 (3): 121–30. PMID 1446976.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Sugie K, Kawakami T, Maeda Y, Kawabe T, Uchida A, Yodoi J (Oct 1991). "Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation". Proceedings of the National Academy of Sciences of the United States of America. 88 (20): 9132–5. doi:10.1073/pnas.88.20.9132. PMC 52666. PMID 1717997.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Bettler B, Hofstetter H, Rao M, Yokoyama WM, Kilchherr F, Conrad DH (Oct 1989). "Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII)". Proceedings of the National Academy of Sciences of the United States of America. 86 (19): 7566–70. doi:10.1073/pnas.86.19.7566. PMC 298106. PMID 2529542.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Kikutani H, Inui S, Sato R, Barsumian EL, Owaki H, Yamasaki K, Kaisho T, Uchibayashi N, Hardy RR, Hirano T (Dec 1986). "Molecular structure of human lymphocyte receptor for immunoglobulin E". Cell. 47 (5): 657–65. doi:10.1016/0092-8674(86)90508-8. PMID 2877743.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Ikuta K, Takami M, Kim CW, Honjo T, Miyoshi T, Tagaya Y, Kawabe T, Yodoi J (Feb 1987). "Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins". Proceedings of the National Academy of Sciences of the United States of America. 84 (3): 819–23. doi:10.1073/pnas.84.3.819. PMC 304307. PMID 2949326.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Yokota A, Kikutani H, Tanaka T, Sato R, Barsumian EL, Suemura M, Kishimoto T (Nov 1988). "Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression". Cell. 55 (4): 611–8. doi:10.1016/0092-8674(88)90219-X. PMID 2972386.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Lüdin C, Hofstetter H, Sarfati M, Levy CA, Suter U, Alaimo D, Kilchherr E, Frost H, Delespesse G (Jan 1987). "Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor". The EMBO Journal. 6 (1): 109–14. PMC 553364. PMID 3034567.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Aubry JP, Pochon S, Gauchat JF, Nueda-Marin A, Holers VM, Graber P, Siegfried C, Bonnefoy JY (Jun 1994). "CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21". Journal of Immunology. 152 (12): 5806–13. PMID 7515913.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C (Jul 1995). "CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18". Immunity. 3 (1): 119–25. doi:10.1016/1074-7613(95)90164-7. PMID 7621072.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Maruyama K, Sugano S (Jan 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Padlan EA, Helm BA (1994). "Modeling of the lectin-homology domains of the human and murine low-affinity Fc epsilon receptor (Fc epsilon RII/CD23)". Receptor. 3 (4): 325–41. PMID 8142907.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Trask B, Fertitta A, Christensen M, Youngblom J, Bergmann A, Copeland A, de Jong P, Mohrenweiser H, Olsen A, Carrano A (Jan 1993). "Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes or DNA markers". Genomics. 15 (1): 133–45. doi:10.1006/geno.1993.1021. PMID 8432525.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Chirmule N, Kalyanaraman VS, Lederman S, Oyaizu N, Yagura H, Yellin MJ, Chess L, Pahwa S (Mar 1993). "HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6". Journal of Immunology. 150 (6): 2478–86. PMID 8450224.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Förster HH, Wäsch R, Kretschmar T, Mischke D, Uchańska-Ziegler B, Ziegler A, Schmitt M, Wahn HU (Nov 1995). "Genetic markers on chromosome 19p and prenatal diagnosis of HLA class II-deficient combined immunodeficiency". Pediatric Research. 38 (5): 812–6. doi:10.1203/00006450-199511000-00029. PMID 8552454.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Bajorath J, Aruffo A (Feb 1996). "Structure-based modeling of the ligand binding domain of the human cell surface receptor CD23 and comparison of two independently derived molecular models". Protein Science. 5 (2): 240–7. doi:10.1002/pro.5560050207. PMC 2143337. PMID 8745401.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Frémeaux-Bacchi V, Bernard I, Maillet F, Mani JC, Fontaine M, Bonnefoy JY, Kazatchkine MD, Fischer E (Jul 1996). "Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23". European Journal of Immunology. 26 (7): 1497–503. doi:10.1002/eji.1830260714. PMID 8766552.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>

External links